{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:56:28Z","timestamp":1791921388437,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","award":["ORIP S10 OD028685"],"award-info":[{"award-number":["ORIP S10 OD028685"]}],"id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","award":["P30 CA08748"],"award-info":[{"award-number":["P30 CA08748"]}],"id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA251138"],"award-info":[{"award-number":["R01 CA251138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","award":["8023-20"],"award-info":[{"award-number":["8023-20"]}],"id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008478","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA251138"],"award-info":[{"award-number":["R01 CA251138"]}],"id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008478","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA254838-01"],"award-info":[{"award-number":["P50 CA254838-01"]}],"id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008478","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA242020"],"award-info":[{"award-number":["R01 CA242020"]}],"id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019714","name":"Foundation Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["1344-18"],"award-info":[{"award-number":["1344-18"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["R01 HL151651"],"award-info":[{"award-number":["R01 HL151651"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["T32GM007739"],"award-info":[{"award-number":["T32GM007739"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128239"],"award-info":[{"award-number":["R01 HL128239"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL151651"],"award-info":[{"award-number":["R01 HL151651"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P50 CA254838-01"],"award-info":[{"award-number":["P50 CA254838-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 CA242020"],"award-info":[{"award-number":["R01 CA242020"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ccell.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T10:38:52Z","timestamp":1671705532000},"page":"164-180.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Eric","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mario Bello","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Phillipp","family":"Bewersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Tittley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahan","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnana","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Fagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Creger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ching","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Bossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrin M.","family":"Beaupre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-6171","authenticated-orcid":false,"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)61727-9","article-title":"Acute myeloid leukaemia in adults","volume":"381","author":"Ferrara","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.002_bib3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ajh.25162","article-title":"Very poor long-term survival in past and more recent studies for relapsed AML patients: the ECOG-ACRIN experience","volume":"93","author":"Ganzel","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ccell.2022.12.002_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.2005.06.027","article-title":"Prognostic index for adult patients with acute myeloid leukemia in first relapse","volume":"23","author":"Breems","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","article-title":"The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells","volume":"9","author":"Nechiporuk","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.002_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s43018-020-0103-x","article-title":"Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia","volume":"1","author":"Zhang","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2022.12.002_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.1771409","article-title":"Mouse models of human AML accurately predict chemotherapy response","volume":"23","author":"Zuber","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood.2021012775","article-title":"Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL","volume":"139","author":"Blombery","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nm.4125","article-title":"Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia","volume":"22","author":"Li","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-021-04206-7","article-title":"Non-genetic determinants of malignant clonal fitness at single-cell resolution","volume":"601","author":"Fennell","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.002_bib13","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V86.5.1903.bloodjournal8651903","article-title":"Expression of bcl-xL can confer a multidrug resistance phenotype","volume":"86","author":"Minn","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2022.12.002_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","article-title":"Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells","volume":"27","author":"Jones","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature14888","article-title":"BET inhibitor resistance emerges from leukaemia stem cells","volume":"525","author":"Fong","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature14898","article-title":"Transcriptional plasticity promotes primary and acquired resistance to BET inhibition","volume":"525","author":"Rathert","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1470-2045(18)30010-X","article-title":"Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study","volume":"19","author":"DiNardo","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2022.12.002_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2005.05.026","article-title":"Regulation of apoptosis by alternative pre-mRNA splicing","volume":"19","author":"Schwerk","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib24","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/s41467-018-07901-8","article-title":"Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities","volume":"9","author":"Sanson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41375-020-1003-x","article-title":"Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network","volume":"35","author":"Gu","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2022.12.002_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.exphem.2013.12.004","article-title":"Mechanisms of resistance to azacitidine in human leukemia cell lines","volume":"42","author":"Sripayap","year":"2014","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ccell.2022.12.002_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-binding protein network in acute myeloid leukemia","volume":"35","author":"Wang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-1436","article-title":"Posttranslational regulation of the exon skipping machinery controls aberrant splicing in leukemia","volume":"10","author":"Zhou","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.stem.2020.12.005","article-title":"Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41590-022-01314-y","article-title":"NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia","volume":"23","author":"Witkowski","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"eabj8357","DOI":"10.1126\/sciadv.abj8357","article-title":"SF3B1 homeostasis is critical for survival and therapeutic response in T\u00a0cell leukemia","volume":"8","author":"Han","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ccell.2022.12.002_bib32","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/bloodadvances.2020004173","article-title":"Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax","volume":"5","author":"Lachowiez","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ccell.2022.12.002_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nbt.3235","article-title":"Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains","volume":"33","author":"Shi","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.002_bib34","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood.V79.9.2378.2378","article-title":"Frequent mutations in the p53 gene in human myeloid leukemia cell lines","volume":"79","author":"Sugimoto","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"High-Resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib36","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1093\/nar\/gkx225","article-title":"An RRM-ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion","volume":"45","author":"Collins","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nmeth.3810","article-title":"Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)","volume":"13","author":"Van Nostrand","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2022.12.002_bib38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1097-2765(03)00054-6","article-title":"Mechanism of XIAP-mediated inhibition of caspase-9","volume":"11","author":"Shiozaki","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/35065125","article-title":"A conserved XIAP-interaction motif in caspase-9 and Smac\/DIABLO regulates caspase activity and apoptosis","volume":"410","author":"Srinivasula","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib40","first-page":"781","article-title":"Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain","volume":"104","author":"Huang","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0092-8674(01)00274-4","article-title":"Structural basis for the inhibition of caspase-3 by XIAP","volume":"104","author":"Riedl","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s43018-021-00177-w","article-title":"Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia","volume":"2","author":"Hashimoto","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2022.12.002_bib43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib44","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1073\/pnas.91.23.10824","article-title":"Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors","volume":"91","author":"Gui","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2022.12.002_bib45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molcel.2016.05.034","article-title":"Release of SR proteins from CLK1 by SRPK1: a symbiotic kinase system for phosphorylation control of pre-mRNA splicing","volume":"63","author":"Aubol","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib46","doi-asserted-by":"crossref","first-page":"24569","DOI":"10.1074\/jbc.271.40.24569","article-title":"SRPK1 and Clk\/Sty protein kinases show distinct substrate specificities for serine\/arginine-rich splicing factors","volume":"271","author":"Colwill","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2022.12.002_bib47","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1128\/MCB.19.10.6991","article-title":"The protein kinase Clk\/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing","volume":"19","author":"Prasad","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2022.12.002_bib48","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1093\/nar\/gkr195","article-title":"Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A","volume":"39","author":"Qian","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib49","doi-asserted-by":"crossref","first-page":"28660","DOI":"10.1074\/jbc.M802645200","article-title":"Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome","volume":"283","author":"Shi","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2022.12.002_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2091-7-7","article-title":"The protein kinase DYRK1A phosphorylates the splicing factor SF3b1\/SAP155 at Thr434, a novel in\u00a0vivo phosphorylation site","volume":"7","author":"de Graaf","year":"2006","journal-title":"BMC Biochem."},{"key":"10.1016\/j.ccell.2022.12.002_bib51","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2022.12.002_bib52","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","article-title":"A20 negatively regulates T\u00a0cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains","volume":"182","author":"D\u00fcwel","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2022.12.002_bib53","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2022.12.002_bib54","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","article-title":"Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia","volume":"167","author":"Sykes","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.09.010","article-title":"A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs","volume":"143","author":"Kim","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","article-title":"Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells","volume":"4","author":"Somervaille","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41467-018-08150-5","article-title":"Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators","volume":"10","author":"Aird","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.002_bib59","doi-asserted-by":"crossref","first-page":"e121438","DOI":"10.1172\/jci.insight.121438","article-title":"Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies","volume":"3","author":"Ten Hacken","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ccell.2022.12.002_bib60","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21\u00a0days to patients with solid tumors","volume":"32","author":"Hong","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ccell.2022.12.002_bib61","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-13-0485","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors","volume":"19","author":"Eskens","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib63","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.3390\/ijms22116047","article-title":"Dual-specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) in human disease, an overview","volume":"22","author":"Lindberg","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccell.2022.12.002_bib64","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.3390\/ijms21207549","article-title":"Cdc-like kinases (CLKs): biology, chemical probes, and therapeutic potential","volume":"21","author":"Mart\u00edn Moyano","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccell.2022.12.002_bib65","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1242\/jcs.00618","article-title":"DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly","volume":"116","author":"Alvarez","year":"2003","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ccell.2022.12.002_bib66","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.jmb.2013.05.013","article-title":"Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases","volume":"425","author":"Aubol","year":"2013","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ccell.2022.12.002_bib67","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20021167","article-title":"Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway","volume":"196","author":"Kamachi","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib68","doi-asserted-by":"crossref","first-page":"44848","DOI":"10.1074\/jbc.M106291200","article-title":"FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1","volume":"276","author":"Chalfant","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2022.12.002_bib69","doi-asserted-by":"crossref","first-page":"CT112","DOI":"10.1158\/1538-7445.AM2021-CT112","article-title":"Abstract CT112: initial results from a Phase 1 trial of a first-in-class pan-CDC-like kinase inhibitor (SM08502) with proof of mechanism in subjects with advanced solid tumors","volume":"81","author":"Tolcher","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib70","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1016\/j.annonc.2022.07.580","article-title":"451O Preliminary evidence of clinical activity from phase I and Ib trials of the CLK\/DYRK inhibitor cirtuvivint (CIRT) in subjects with advanced solid tumors","volume":"33","author":"Scott","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2022.12.002_bib71","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1200\/JCO.2022.40.16_suppl.3080","article-title":"A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors","volume":"40","author":"Shimizu","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2022.12.002_bib72","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/emmm.201302663","article-title":"Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation","volume":"5","author":"Wang","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib73","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.002_bib74","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.002_bib75","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","article-title":"Genomic correlates of immune-cell infiltrates in colorectal carcinoma","volume":"15","author":"Giannakis","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2022.12.002_bib76","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/ajmg.a.34190","article-title":"Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene","volume":"155A","author":"Gripp","year":"2011","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ccell.2022.12.002_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41375-019-0485-x","article-title":"Genetic characterization of ABT-199 sensitivity in human AML","volume":"34","author":"Bisaillon","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2022.12.002_bib78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","article-title":"Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation","volume":"30","author":"Obeng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib79","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nm.4165","article-title":"Therapeutic targeting of splicing in cancer","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib80","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2022.12.002_bib81","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular Oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.ccell.2022.12.002_bib82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10, 000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2022.12.002_bib83","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.002_bib84","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.molcel.2018.02.011","article-title":"LKB1, salt-inducible kinases, and MEF2C are linked dependencies in acute myeloid leukemia","volume":"69","author":"Tarumoto","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib85","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.3583","article-title":"Analyzing CRISPR genome-editing experiments with CRISPResso","volume":"34","author":"Pinello","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.002_bib86","doi-asserted-by":"crossref","first-page":"e0224137","DOI":"10.1371\/journal.pone.0224137","article-title":"Statistical determination of synergy based on Bliss definition of drugs independence","volume":"14","author":"Demidenko","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2022.12.002_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cels.2018.07.001","article-title":"Coral: clear and customizable visualization of human kinome data","volume":"7","author":"Metz","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.ccell.2022.12.002_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. J."},{"key":"10.1016\/j.ccell.2022.12.002_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.002_bib90","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.ccell.2022.12.002_bib91","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib92","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.002_bib93","doi-asserted-by":"crossref","first-page":"D64","DOI":"10.1093\/nar\/gks1048","article-title":"The UCSC Genome Browser database: extensions and updates 2013","volume":"41","author":"Meyer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib94","doi-asserted-by":"crossref","first-page":"D48","DOI":"10.1093\/nar\/gks1236","article-title":"Ensembl 2013","volume":"41","author":"Flicek","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.002_bib95","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nmeth.1528","article-title":"Analysis and design of RNA sequencing experiments for identifying isoform regulation","volume":"7","author":"Katz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2022.12.002_bib96","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ccell.2022.12.002_bib97","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2022.12.002_bib98","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2022.12.002_bib99","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.002_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2022.12.002_bib101","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"Journal of open source software"},{"key":"10.1016\/j.ccell.2022.12.002_bib102","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.002_bib103","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bioinformatics\/bts731","article-title":"NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets","volume":"29","author":"Breese","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.002_bib104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.002_bib105","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.molcel.2022.05.019","article-title":"Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation","volume":"82","author":"Huppertz","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2022.12.002_bib106","doi-asserted-by":"crossref","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","article-title":"Software for computing and annotating genomic ranges","volume":"9","author":"Lawrence","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ccell.2022.12.002_bib107","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nmeth.3885","article-title":"Data-driven hypothesis weighting increases detection power in genome-scale multiple testing","volume":"13","author":"Ignatiadis","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2022.12.002_bib108","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610822005888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610822005888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:11:25Z","timestamp":1778623885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610822005888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1535610822005888"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2022.12.002","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}